Case
Maine Yankee Atomic Power Co. v. United States, 44 Fed. Cl. 372 (1999).
Case | Federal Claims | July 27, 1999Based on California Statute of Limitations, Novartis Obtains Dismissal of Zometa Case for 2nd Time
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | August 19, 2014Judge Michael W. Fitzgerald of the District Court for the Central District of California held, for the second time, that plaintiff’s claims are time-barred under California law and that plaintiff is unable to take advantage of…
Hassayampa Steering Comm. v. Arizona, 768 F. Supp. 697 (D. Ariz. 1991)
Case | Environmental | April 30, 1991Harbor Court Assoc. v. Kiewit Constr. Co., 6 F. Supp. 2d 449 (D. Md. 1998)
Case | Insurance Coverage | April 24, 1998Significant Victory for Porter Hayden in Asbestos Coverage Dispute over Exhaustion of Insurers’ Excess Policies
Case | Insurance Coverage | January 2, 2014Porter Hayden prevailed on a significant coverage dispute when the U.S. District Court for the District of Maryland confirmed that Maryland’s “horizontal exhaustion” rule requires only exhaustion of the primary policies in a particular year on…
Porter Hayden wins ruling that insurance coverage is an asset surviving bankruptcy and defeats insurer’s motion to indemnify Porter Hayden only for actual, discounted payments of its bankruptcy-settlement trust.
Case | Insurance Coverage | March 6, 2012On March 6, 2012, the United States District Court for the District of Maryland ruled in favor of arguments made by Hollingsworth LLP, that insurance coverage is an asset surviving bankruptcy and that Porter Hayden Company…
Louisiana Federal Court Grants Summary Judgment to Novartis After Excluding Plaintiff’s Expert Witnesses
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | June 14, 2013The U.S. District Court for the Western District of Louisiana granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s causation expert witnesses and then granted summary judgment in favor of Novartis in Perkins v. Novartis…
Novartis Wins Summary Judgment in Rhode Island Aredia Case
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | December 19, 2012Chief Judge Mary Lisi of the U.S. District Court for the District of Rhode Island adopted Magistrate Judge Lincoln Almond’s recommendation and entered judgment in favor of Novartis in Patterson v. Novartis Pharm. Corp., No. 1:11-402-ML-LDA…
Federal District Court Dismisses Putative Class Action Against Sherwin-Williams
Case | Products Liability & Toxic Torts | Environmental | August 21, 2018A federal district court judge granted The Sherwin-Williams Company’s motion to dismiss an environmental and toxic tort class action. Plaintiffs in Brad Lafferty, et al. v. The Sherwin-Williams Company, Case No. 1:17-cv-06321 (D.N.J. Aug. 21, 2018)…
Federal Court Holds N.J. Statute Precludes Punitive Damages and “fraud” Exception is Preempted
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | July 31, 2018A federal district court judge has precluded plaintiffs from seeking punitive damages at trial in a product liability case involving one of Novartis Pharmaceuticals Corporation’s cancer therapies. On July 31, 2018, Judge Robin L. Rosenberg of…